Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
48.35
-0.95 (-1.93%)
Apr 2, 2025, 1:30 PM CST

Medigen Vaccine Biologics Revenue

In the year 2024, Medigen Vaccine Biologics had annual revenue of 605.64M TWD with 55.44% growth. Medigen Vaccine Biologics had revenue of 128.81M in the quarter ending December 31, 2024, a decrease of -24.82%.

Revenue
605.64M
Revenue Growth
+55.44%
P/S Ratio
26.24
Revenue / Employee
5.88M
Employees
103
Market Cap
15.89B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024605.64M216.01M55.44%
Dec 31, 2023389.62M24.58M6.73%
Dec 31, 2022365.04M-2.92B-88.87%
Dec 31, 20213.28B3.27B28,413.03%
Dec 31, 202011.51M10.39M927.41%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition